₨ Official source-observed price
PKR 6,979.97
3x10's
PKR 232.67 / tablet
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 232.67/ tablet
Price positionNear medianvs like-for-like peer median
Peer comparators48current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Tenofovir disoproxil
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05
- Strength
- 300 mg
- Dosage form
- Tablet
- Pack
- 3x10's
- Registration no.
- 067529
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Maple Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 6,979.97 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 6,651.40 | 2025-11-04 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Same generic
Other listed brands
Agfo 300 mgAGP Limited · PKR 4,873.71AVONZA 300 mgAGP Limited · PKR 9,754.42Devire 300 mgWilshire Laboratories (Private) Limited · PKR 5,769.43Entenof 300 mgBosch Pharmaceuticals (Pvt) Ltd. · PKR 6,698.18Epivir 200 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 7,573.14Fovirox 300 mgNabiqasim Industries (Pvt) Ltd., · PKR 6,881.85Frolot 300 mgMartin Dow Limited · PKR 6,881.85Frolot 300 mgMartin Dow Limited · PKR 229.42
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 067529MedInfoBase. (2026). TANVIRE 300 mg Tablet (3x10's), Maple Pharmaceuticals (Pvt.) Ltd. — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/tanvire-300-mg-067529-3x10s-maple-pharmaceuticals-pvt-ltd/ Data observed 24 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 067529.
MedInfoBase. TANVIRE 300 mg Tablet (3x10's), Maple Pharmaceuticals (Pvt.) Ltd. — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/tanvire-300-mg-067529-3x10s-maple-pharmaceuticals-pvt-ltd/ Data observed 24 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 067529.
MedInfoBase (2026) TANVIRE 300 mg Tablet (3x10's), Maple Pharmaceuticals (Pvt.) Ltd. — registration and price record. Available at: https://medinfobase.com/brand/tanvire-300-mg-067529-3x10s-maple-pharmaceuticals-pvt-ltd/ (Accessed: 23 September 2026).
"TANVIRE 300 mg Tablet (3x10's), Maple Pharmaceuticals (Pvt.) Ltd. — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/tanvire-300-mg-067529-3x10s-maple-pharmaceuticals-pvt-ltd/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "TANVIRE 300 mg Tablet (3x10's), Maple Pharmaceuticals (Pvt.) Ltd. — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/tanvire-300-mg-067529-3x10s-maple-pharmaceuticals-pvt-ltd/.
Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.